Softwr

Healthcare · head to head

Paige vs Visage Imaging

Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite
Visage Imaging logo

Visage Imaging

Healthcare

Server-side streaming PACS built for radiologists reading very large studies over thin connections

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.; Visage Imaging pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • They diverge on capability: Paige covers Paige Prostate Detect, Visage Imaging covers Server-side rendering.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Paige and Visage Imaging actually diverge.

Attributes where Paige and Visage Imaging differ
AttributePaigeVisage Imaging
PlatformsWeb, Cloud, On-premiseWindows, macOS, Web, iOS, Cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

Only in Visage Imaging

  • Server-side rendering
  • One Viewer
  • Native multi-dimensional tools
  • Digital breast tomosynthesis reading
  • Open archive
  • Cloud PACS operations
  • AI accelerator
  • On the fly patient jacket

What people use each for

The jobs each tool is most often brought in to do.

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Visage Imaging
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Visage Imaging
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Visage Imaging
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Visage Imaging

Visage Imaging

  • An academic health system whose radiologists read from home and cannot tolerate a thousand slice CT taking minutes to opennot Paige
  • A breast imaging service moving to tomosynthesis where study sizes have made the existing PACS unusable at volumenot Paige
  • A teleradiology group covering many client sites that needs one viewer rather than a client-specific workstation per contractnot Paige
  • A health system mid migration that needs priors from three legacy archives assembled into one patient jacket before the data move finishesnot Paige

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Visage Imaging

  • Pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • Module breadth outside radiology is narrower than at Sectra or the large modality vendors, so a group planning to digitise pathology on the same platform will not find it here.
  • Server-side rendering shifts the cost to central infrastructure, so the saving on radiologist workstations is partly offset by what you spend on servers or cloud compute.
  • Pro Medicus concentrates on very large contracts, and smaller imaging groups report long sales cycles and little appetite from the vendor for deals below a certain volume.
  • Diagnostic AI is third party, surfaced through the accelerator framework rather than developed in house, so algorithm licensing, validation and monitoring remain the buyer problem.

Pricing, plan by plan

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Visage Imaging

On request
  • Visage 7 enterprise contract$undefined/year
    • Transaction pricing per exam with a minimum annual volume commitment
    • Seven to ten year terms typical for health system contracts
    • Contract totals for major deals are disclosed by Pro Medicus to the ASX

Which should you pick?

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Choose Visage Imaging if

  • You need server-side rendering.
  • You work on Windows, macOS, Web, iOS, Cloud.
  • You also want one viewer.
Visage Imaging review

Questions people ask

Is Paige or Visage Imaging better?
Neither clearly leads. Paige starts at On request and Visage Imaging at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Paige or Visage Imaging?
Paige starts at On request and Visage Imaging at On request.
Does Paige or Visage Imaging run on more platforms?
Paige runs on Web, Cloud, On-premise. Visage Imaging runs on Windows, macOS, Web, iOS, Cloud.
What is Paige best used for?
Paige is most often used for a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable, a pathology department already digitised that wants a documented safety net against missed small foci of cancer, a hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reporting, a pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variability. Of those, a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable and a pathology department already digitised that wants a documented safety net against missed small foci of cancer are not what Visage Imaging is typically brought in for.
What can Paige do that Visage Imaging cannot?
Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications. Visage Imaging covers Server-side rendering, One Viewer, Native multi-dimensional tools, Digital breast tomosynthesis reading.

Answered from the vendors’ own pages

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Visage Imaging: Who owns Visage Imaging?

Pro Medicus Limited, listed on the Australian Securities Exchange. That listing means major contract values and terms are publicly announced.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Visage Imaging: How is Visage priced?

Per exam, against a minimum annual volume, on multi-year terms. Because Pro Medicus discloses large contract totals and durations to the market, buyers can estimate a per exam rate before entering negotiation.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Visage Imaging: Is Visage 7 FDA cleared for diagnostic interpretation?

Yes, Visage 7 holds 510(k) clearance for diagnostic viewing including mammography and tomosynthesis on validated displays. Confirm the exact cleared modality list for your intended use.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Visage Imaging: Does it work as a full cloud PACS?

Yes, Visage 7 runs complete PACS operations in the cloud rather than cloud viewing over an on-premise archive.

Share

Related pages

More on Paige

More on Visage Imaging

Keep looking

Other head to heads